COVID-19: US approves Pfizer-BioNtech vaccine for 12-15 year olds

Washington: The US Food and Drug Administration (FDA) on Monday authorized the use of the Pfizer-BioNTech Covid-19 vaccine in children aged 12 to 15 years old.

Acting FDA commissioner Janet Woodcock described the move as a “significant step in the fight against the COVID-19 pandemic.”

“Today’s action allows for a younger population to be protected from Covid-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic,” Woodcock said in a statement.